Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00015231
DRKS00015231
Recruiting
Phase 3

Prostate bed irradiation with alternative radio-oncological approaches - PAROS

niversitätsklinikum HeidelbergAbteilung RadioOnkologie und Strahlentherapie0 sites897 target enrollmentSeptember 27, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitätsklinikum HeidelbergAbteilung RadioOnkologie und Strahlentherapie
Enrollment
897
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 27, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
niversitätsklinikum HeidelbergAbteilung RadioOnkologie und Strahlentherapie

Eligibility Criteria

Inclusion Criteria

  • •histologically confirmed prostate cancer with classification according to the Gleason score and recent PSA\-value
  • •\- Indication for the irradiation of the prostate bed (adjuvant / salvage) after prostatectomy
  • •\- Karnofsky index \= 70%
  • •\- Age \= 18 years
  • •\- Patient information and written consent
  • •\- Ability of the patient to consent

Exclusion Criteria

  • •\- antihormonal therapy
  • •\- lymphoid metastasis
  • •\- Stage IV (distant metastases)
  • •\- previous radiotherapy in the pelvis
  • •\- hip total endoprosthesis
  • •\- Simultaneous participation in another clinical trial that could influence the results of one of the studies

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA Trial)
2024-520093-34-00Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia310
Completed
Phase 2
A trial of prostate radiotherapy in conjunction with carbogen and nicotinamideProstate cancerCancerMalignant neoplasm of prostate
ISRCTN08912168East and North Hertfordshire Hospitals NHS Trust (UK)50
Active, not recruiting
Phase 1
Prostate Radiotherapy with Oxygen EnhancementTherapeutic area: Diseases [C] - Cancer [C04]Prostate CancerMedDRA version: 14.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2010-021886-63-GBEast and North Hertfordshire NHS Trust50
Active, not recruiting
Phase 1
Artificial Intelligence driven personalisation of radiotherapy and concomitant androgen deprivation therapy for prostate cancer patientsProstate cancerMedDRA version: 20.0Level: PTClassification code: 10060862Term: Prostate cancer Class: 100000004864Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2024-510707-11-00inac-Pet Scan Opco Limited30
Recruiting
Phase 3
Prostate Radiotherapy In high risk and node positive disease comparing Moderate & Extreme hypofractionation.Health Condition 1: null- 1.Participants must be histologically proven, adenocarcinoma prostate.2. Localised to prostate or pelvic lymph nodes.Health Condition 2: N428- Other specified disorders of prostate
CTRI/2018/05/014054Tata Memorial Centre Department of Atomic Energy Clinical Trial Centre